Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Improved Outcome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients by Reducing Caregiver Distress

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by University of Colorado, Denver
Sponsor:
Collaborator:
Patient Centered Outcome Research Institute
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT02037568
First received: January 14, 2014
Last updated: NA
Last verified: January 2014
History: No changes posted
  Purpose

PURPOSE: As this is a randomized controlled trial, all subjects receiving stress management psychoeducation will be expected to obtain a new set of coping skills that will allow them to better deal with the stressors of caregiving for an allogeneic HSCT patient. It is expected that improving caregiver status will improve patient quality of life.


Condition Intervention
Hematopoietic/Lymphoid Cancer
Behavioral: fPER

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: Improved Behavioral Outcome in Allogeneic Hematopoietic Stem Cell Transplant Patients by Reducing Caregiver Distress: Behavioral and Physiological Evidence

Resource links provided by NLM:


Further study details as provided by University of Colorado, Denver:

Primary Outcome Measures:
  • Change in Patient quality of life over time [ Time Frame: Baseline (prior to transplant), 6 weeks, 3 months and 6 months after transplant ] [ Designated as safety issue: No ]
    The total score on the Functional Assessment of Cancer Treatment - Blood/Marrow Transplant (FACT-BMT) is a well validated measure of patient quality of life.

  • Change in Caregiver Distress over time [ Time Frame: Baseline (prior to transplant), 6 weeks, 3 months and 6 months after transplant ] [ Designated as safety issue: No ]
    A composite score is created from a principal component analysis (PCA) that incorporates caregiver PSS, CESD, and STAI similar to our prior studies.


Secondary Outcome Measures:
  • Change in Perceived stress Over Time [ Time Frame: Baseline (prior to transplant), 6 weeks, 3 months and 6 months after transplant ] [ Designated as safety issue: No ]
    The Perceived Stress Scale (PSS) is a well validated 14 item measure of self perceived loss of control.

  • Change in Depression over time [ Time Frame: Baseline (prior to transplant), 6 weeks, 3 months and 6 months after transplant ] [ Designated as safety issue: Yes ]
    Center for Epidemiological Studies Depression Scale is a well validated 20 item scale measuring symptoms. Study psychologists will be notified if any subject scores 16 and over for follow up.

  • Change in Anxiety over time [ Time Frame: Baseline (prior to transplant), 6 weeks, 3 months and 6 months after transplant ] [ Designated as safety issue: No ]
    The 40 item Spielberger State-Trait Anxiety Inventory will assess anxiety in subjects. It is a well validated measure of subject anxiety.

  • Change in adrenal activity over time [ Time Frame: Baseline (prior to transplant), 3 months (caregvier only), and 6 months after transplant in caregivers. ] [ Designated as safety issue: No ]
    Cortisol measured in hair will be used as a retrospective measure of activation of the hypothalamic pituitary adrenal axis.

  • Change in caregiver telomere length over time [ Time Frame: Baseline (prior to transplant), 3 months and 6 months after transplant ] [ Designated as safety issue: No ]
    Telomere length will be assessed as a measure of cellular aging.

  • Change in caregiver telomerase activity over time [ Time Frame: Baseline (prior to transplant), 3 months and 6 months after transplant ] [ Designated as safety issue: No ]
    Telomerase activity will be assessed as a measure of the ability to reverse cellular aging processes.

  • Change in caregiver burden over time [ Time Frame: Baseline (prior to transplant), 6 weeks, 3 months and 6 months after transplant ] [ Designated as safety issue: No ]
    The 24 item caregiver reaction assessment (CRA) will assess caregiver burden.


Estimated Enrollment: 450
Study Start Date: January 2014
Estimated Study Completion Date: October 2016
Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Caregiver Self-Directed
Orientation class; laboratory biomarker analysis; questionnaire administration; survey administration; treatment as usual psychosocial care; caregiver workbook.
Experimental: Caregiver Intervention
Orientation class; laboratory biomarker analysis; questionnaire administration; survey administration; Psychoeducation and Relaxation (fPER), which included one-on-one psychoeducation, and stress management intervention.
Behavioral: fPER
Briefly in order, the sessions will include: 1) Overview and introduction to stress management, 2) Stress and the mind-body connection, 3) How our thoughts can lead to stress, 4) Coping with stress, 5) Strategies for maintaining energy and stamina, 6) Coping with uncertainty and fear of unknown, 7) Managing changing relationships/communicating needs, and 8) Getting the support they need, modeled after a successful intervention for patient groups. Manualization is crucial for successful wider implementation. Sessions 9 and 10 will provide booster sessions in which the interventionist will assess current challenges for the caregiver, provide review, and emphasize further coping skills training that might assist the caregiver in managing current stressors such as coping with the "new normal."
Other Names:
  • Other Names:
  • "fone" PsychoEducation and Relaxation
  • fPER

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • - DISEASE CHARACTERISTICS (Meets all of the following criteria):

    • Patient undergoing allogeneic hematopoietic stem cell transplant (HSCT)
    • Primary caregiver of a BMT patient for 50% of the time
  • PATIENT CHARACTERISTICS:

    • Able to read and speak English
    • Has telephone access
  • CAREGIVER CHARACTERISTICS:

    • Able to read and speak English
    • Willingness to use a Smartphone
    • No serious medical condition likely to influence cortisol assessment in their hair
    • Alcohol consumption limited to < 2 drinks/day
    • Least 18 years of age

Exclusion Criteria:

  • PRIOR CONCURRENT THERAPY:

    • No history of a psychiatric illness unrelated to the HSCT within the past 18 months
    • No steroid medications (caregiver)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02037568

Contacts
Contact: Mark L Laudenslager, PhD 303-724-9276 mark.laudenslager@ucdenver.edu

Locations
United States, Colorado
University of Colorado Hospital Recruiting
Aurora, Colorado, United States, 80045
Contact: Ben W Brewer, PsyD    720-848-1161    benjamin.brewer@ucdenver.edu   
Sub-Investigator: Ben Brewer, PsyD         
Presbyterian/St. Luke's Medical Center (PSLMC) Recruiting
Denver, Colorado, United States, 80218
Contact: Teri Simoneau, PhD    720-754-4850    Teri.Simoneau@HealthONEcares.com   
Sub-Investigator: Terese L Simoneau, PhD         
Sponsors and Collaborators
University of Colorado, Denver
Patient Centered Outcome Research Institute
Investigators
Principal Investigator: Mark L Laudenslager, PhD University of Colorado Denver (Anschutz Medical Campus)
  More Information

No publications provided

Responsible Party: University of Colorado, Denver
ClinicalTrials.gov Identifier: NCT02037568     History of Changes
Other Study ID Numbers: 13-2639
Study First Received: January 14, 2014
Last Updated: January 14, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by University of Colorado, Denver:
depression
stress
caregiving
anxiety
psychoeducation intervention
psycho-oncology
allogeneic hematopoietic stem cell transplant

ClinicalTrials.gov processed this record on November 24, 2014